drugset / Trial / NCT00599404

PK Study to Evaluate Esomeprazole Plasma Levels Following Administration of PN 400

NCT00599404

Phase 1 Completed 18 enrolled POZEN
NaSingle-groupOpen-labelBasic science

Summary

Pharmacokinetic study in healthy subjects with single and repeat b.i.d. dosing of PN 400 tablets from the same drug product batch.

Timeline

Start
2008-01
Primary completion
2008-02
Completion
2008-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Esomeprazole Small molecule 500 mg Oral
Background Naproxen Small molecule 20 mg Oral

Indications

No indication recorded.